IHMRI affiliation

Theme:Diagnostics and Therapeutics

Publications and funding


  • Wilkinson B, Whitehead S, George E, Horton S, Bellaby J, Mohamed S, Ford C, Min SS, Gama R. Do reflex comments on laboratory reports alter patient management? Annals of Clinical Biochemistry.
    Accepted 2020
  • Min SS, Sullivan D, Storman M. A patient with cholestasis, elevated cholestenol, LDL-cholesterol and lipoprotein X. Pathology 2020, 52:599 
  • Mok J, Brown C, Moore A E 8, Min S S, Hampson G. Skeletal response to treatment with teriparatide (TPD) in severe post­ menopausal osteoporosis in real-life setting: effect of age and vitamin D status. Endocr Res. 2018, 13:1-8.
  • Min SS, Wierzbicki A Radiotherapy, Chemotherapy and Atherosclerosis. Curr Opin Cardiol 2017, 32:441-447.
  • Min SS, Mehra V, Clay J, et al. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell­ depleted allogeneic stem cell transplants-single centre pilot study. J Clin Pathol 2017;0:1-5. Doi: 10.1136/jclinpath-2017-204399
  • Weerasinghe S, MacWhannell A, Min S S, Gama R. Hypogonadotropic hypogonadism in Juvenile Haemochromatosis type 28; Recovery with iron depletion. Annals clinical biochem 54; Supp 1. FOCUS 2017-poster 043
  • Min SS, Mehra V, Clay J, et al. Composite biomarker panel in prediction of severity and diagnosis of acute graft-versus-host disease with T-deplete allogeneic stem cell transplants-a single centre pilot study. Blood. 2016; 22:128 
  • Min SS, Dew T, Clay J, Sherwood R, Vincent RP. A biomarker panel for diagnosis of acute graft-versus-host disease. Annals clinical biochem 53; Supp 1. FOCUS 2016-poster TH53
  • Min S, Vithanage N, Vincent RP. Re-audit on osmolality requesting. Annals clinical biochem 52: Supp 1. FOCUS 2015- poster TH58

Current Research Projects/Funding

  • A Double-blind, Randomized , Placebo controlled Multicenler Study to Evaluate the Impact of Evolocumabori Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV) Start date: March 2019 Other investigators: Multicentre trial sites
  • Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoproteln (a) levels among patients with established cardiovascular disease. Start date: March 2019

Other roles

  • NSW Health Chemical Pathology covering ISLHD, SLHD, SWSLHD

  • Honorary Clinical Senior Lecturer- University of Wollongong Graduate Medical School